The Annals Visit the NEW pharmaCE.com
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 13 July 2004, www.theannals.com, DOI 10.1345/aph.1E024.
 The Annals of Pharmacotherapy: Vol. 38, No. 9, pp. 1509-1514. DOI 10.1345/aph.1E024
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, D. F
Right arrow Articles by Callen, E. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, D. F
Right arrow Articles by Callen, E. D

NEW DRUG APPROVALS

Soluble or Insoluble Prussian Blue for Radiocesium and Thallium Poisoning?

Dennis F Thompson, PharmD FASHP FCCP

Associate Dean, Professor and Chair, Department of Pharmacy Practice, College of Pharmacy, Southwestern Oklahoma State University, Weatherford, OK

Erin D Callen, PharmD

Assistant Professor of Pharmacy Practice, College of Pharmacy, Southwestern Oklahoma State University

Reprints: Dennis F Thompson PharmD FASHP FCCP, Department of Pharmacy Practice, Southwestern Oklahoma State University, c/o St. Anthony Hospital, 1000 N. Lee, Oklahoma City, OK 73102-1080, fax 405/272-6917, dennis.thompson{at}swosu.edu

OBJECTIVE: To review the available English-language literature concerning the efficacy of soluble and insoluble Prussian blue used as a therapeutic agent in radiocesium and thallium poisoning.

DATA SOURCES: A thorough search of MEDLINE, Toxline, and EMBASE databases (1960s–August 2003) was performed. Search terms included Prussian blue, thallium, and radiocesium poisoning. Bibliographies of relevant papers were reviewed for additional citations.

STUDY SELECTION AND DATA EXTRACTION: Reports and studies of human trials and cases, along with animal and relevant in vitro data, were sought. Data were categorized as insoluble and soluble Prussian blue and by thallium and radiocesium poisoning.

DATA SYNTHESIS: The majority of evidence describing the efficacy of Prussian blue for radiocesium poisoning is based on the use of the insoluble form. In contrast, the majority of data supporting the efficacy of Prussian blue in thallium poisoning involves the use of the soluble form.

CONCLUSIONS: Insoluble Prussian blue has recently been approved in the US for treatment of both thallium and radiocesium poisoning. While there is sufficient evidence that the insoluble form of Prussian blue is effective in radiocesium poisoning, there is a paucity of analogous data supporting its use in thallium poisoning. Whether the physicochemical differences between soluble and insoluble Prussian blue have any effect on outcomes in human poisoning is not known.

Key Words: Prussian blue, radiocesium, thallium

Published Online, July 13, 2004. www.theannals.com, DOI 10.1345/aph.1E024




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.